SCHEMBL18152295

SCHEMBL18152295

CC(C)(C)OC(=O)N1CC[C@@H](Oc2ccc(C(=O)O)cc2-c2ccc(F)c(F)c2)C1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BCL9 O00512 10/20 0.47
CTNNB1 P35222 10/20 0.47
GPR119 Q8TDV5 1/20 0.47
TOP2A P11388 1/20 0.46
PIK3CD O00329 2/20 0.46
PIK3CA P42336 2/20 0.46
PIK3CB P42338 2/20 0.46
PIK3CG P48736 2/20 0.46
PDE4B Q07343 3/20 0.45
PDE4D Q08499 3/20 0.45
PDE4A P27815 2/20 0.45
PDE4C Q08493 2/20 0.45
USP30 Q70CQ3 1/20 0.43
MMP13 P45452 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30350445 1.00 BCL9 (0.47) BCL9CTNNB1GPR119TOP2APIK3CD
SCHEMBL18152414 1.00 BCL9 (0.47) BCL9CTNNB1GPR119TOP2APIK3CD
SCHEMBL18152297 1.00 BCL9 (0.47) BCL9CTNNB1GPR119TOP2APIK3CD
SCHEMBL18152370 0.92 BCL9 (0.48) BCL9CTNNB1USP30
SCHEMBL30392132 0.91 PIK3CD (0.47) BCL9CTNNB1GPR119PIK3CDPIK3CA
SCHEMBL30350485 0.91 PIK3CD (0.47) BCL9CTNNB1GPR119PIK3CDPIK3CA
SCHEMBL18152375 0.91 TOP2A (0.47) BCL9CTNNB1GPR119TOP2APIK3CD
SCHEMBL18152288 0.91 TOP2A (0.47) BCL9CTNNB1GPR119TOP2APIK3CD
SCHEMBL18152287 0.91 TOP2A (0.47) BCL9CTNNB1GPR119TOP2APIK3CD
SCHEMBL30643913 0.88 GPR119 (0.47) GPR119PIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016168524-A1 SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-10-20 WO disclosed